北美人类肝脏模型市场预测至 2028 年 - COVID-19 影响和按类型划分的区域分析（肝脏类器官、芯片肝脏、2D 模型、3D 生物打印等）、应用（药物发现、教育等） ）和最终用户（制药和生物技术公司、研究机构等）

TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Human Liver Models Market By Type
1.3.2 North America Human Liver Models Market By Application
1.3.3 North America Human Liver Models Market By End User
1.3.4 North America Human Liver Models Market By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Human Liver Models Market Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Human Liver Models Market Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Liver Diseases
5.1.2 Increasing Focus on Developing Alternatives for Animal Testing Models
5.2 Market Restraints
5.2.1 Expensive Liver Models
5.3 Market Opportunities
5.3.1 Escalating Focus on Drug Discovery Activities
5.4 Future Trends
5.4.1 Surging Technology Advancements in Organ Printing.
5.5 Impact analysis
6. Human Liver Models Market North America Analysis
6.1 North America Human Liver Models Market Revenue Forecast and Analysis
7. North America Human Liver Models Market Analysis By Type
7.1 Overview
7.2 North America Human Liver Models Market Revenue Share, by Type (2021 and 2028)
7.3 Liver Organoids
7.3.1 Overview
7.3.2 Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.4 Liver-on-a-chip
7.4.1 Overview
7.4.2 Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.5 2D Models
7.5.1 Overview
7.5.2 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.6 3D Bioprinting
7.6.1 Overview
7.6.2 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.7 Others
7.7.1 Overview
7.7.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8. North America Human Liver Models Market Analysis By Application
8.1 Overview
8.2 North America Human Liver Models Market Share, by Application, 2021 and 2028, (%)
8.3 Educational
8.3.1 Overview
8.3.2 Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.4 Drug Discovery
8.4.1 Overview
8.4.2 Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.5 Other
8.5.1 Overview
8.5.2 Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9. North America Human Liver Models Market Analysis By End User
9.1 Overview
9.2 North America Human Liver Models Market Share, by End User, 2021 and 2028, (%)
9.3 Research Institutes
9.3.1 Overview
9.3.2 Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.5 Others
9.5.1 Overview
9.5.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
10. North America Human Liver Models Market Country Analysis
10.1 North America: Human Liver Models Market
10.1.1 Overview
10.1.2 North America: Human Liver Models Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.1 US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.2 US: Human Liver Models Market, by Type, 20192028 (US$ Thousand)
10.1.2.1.3 US: Human Liver Models Market, by Application, 20192028 (US$ Thousand)
10.1.2.1.4 US: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
10.1.2.2 Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.1 Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.2 Canada: Human Liver Models Market, by Type, 20192028 (US$ Thousand)
10.1.2.2.3 Canada: Human Liver Models Market, by Application, 20192028 (US$ Thousand)
10.1.2.2.4 Canada: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
10.1.2.3 Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.1 Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.2 Mexico: Human Liver Models Market, by Type 20192028 (US$ Thousand)
10.1.2.3.3 Mexico: Human Liver Models Market, by Application 20192028 (US$ Thousand)
10.1.2.3.4 Mexico: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
11. Impact Of COVID-19 Pandemic on North America Human Liver Models Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Emulate, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 MIMETAS BV
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 InSphero
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 BioIVT
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 CELLINK
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 inancial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Kerafast
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 ORGANOVO HOLDINGS INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms


LIST OF TABLES
Table 1. North America Human Liver Models Market, Revenue and Forecast, 20192028 (US$ Thousand)
Table 2. US: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 3. US: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 4. US Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 5. Canada Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 6. Canada Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 7. Canada Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 8. Mexico Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 9. Mexico Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 10. Mexico Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 11. Organic Developments Done by Companies
Table 12. Inorganic Developments Done by Companies
Table 13. Glossary of Terms


LIST OF FIGURES
Figure 1. North America Human Liver Models Market Segmentation
Figure 2. North America Human Liver Models Market Segmentation, By Country
Figure 3. North America Human Liver Models Market Overview
Figure 4. Liver Organoids Held the Largest Share in 2020
Figure 5. The US to Show Significant Growth During Forecast Period
Figure 6. North America PEST Analysis
Figure 7. North America Human Liver Models Market Impact Analysis of Drivers and Restraints
Figure 8. North America Human Liver Models Market Revenue Forecast and Analysis
Figure 9. North America Human Liver Models Market Revenue Share, by Type (2021 and 2028)
Figure 10. North America Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 11. North America Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 12. North America 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 13. North America 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 14. North America Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 15. North America Human Liver Models Market Share, by Application, 2021 and 2028 (%)
Figure 16. North America Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 17. North America Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 18. North America Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 19. North America Human Liver Models Market Share, by End User, 2021 and 2028 (%)
Figure 20. North America Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 21. North America Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 22. North America Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 23. North America: Human Liver Models Market, by Key Country Revenue (2021) (US$ Thousand)
Figure 24. North America: Human Liver Models Market, by Country, 2021 & 2028 (%)
Figure 25. US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 26. Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 27. Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 28. Impact of COVID-19 Pandemic in North American Country Markets

1. BioIVT
2. CELLINK
3. Emulate, Inc.
4. InSphero
5. Kerafast
6. MIMETAS BV
7. ORGANOVO HOLDINGS INC.
8. THERMO FISHER SCIENTIFIC INC.

- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America human liver models market. - Highlights key business priorities in order to assist companies to realign their business strategies - The key findings and recommendations highlight crucial progressive industry trends in the North America human liver models market, thereby allowing players across the value chain to develop effective long-term strategies - Develop/modify business expansion plans by using substantial growth offering developed and emerging markets - Scrutinize in-depth North America market trends and outlook coupled with the factors driving the human liver models market, as well as those hindering it - Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name	Select Country Afghanistan Aland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Caribbean Netherlands Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, Democratic Republic of Cook Islands Costa Rica Côte d’Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard and McDonald Islands Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States of Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Korea Northern Mariana Islands Norway Oman Pakistan Palau Palestine, State of Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Réunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Saint-Martin (France) Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Korea South Sudan Spain Sri Lanka St. Pierre and Miquelon Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand The Netherlands Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Vatican Venezuela Vietnam Virgin Islands (British) Virgin Islands (U.S.) Wallis and Futuna Islands Western Sahara Yemen Zambia Zimbabwe
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.